These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26342440)

  • 1. Cellular localization of iron(II) polypyridyl complexes determines their anticancer action mechanisms.
    Chen J; Luo Z; Zhao Z; Xie L; Zheng W; Chen T
    Biomaterials; 2015 Dec; 71():168-177. PubMed ID: 26342440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ruthenium complexes with phenylterpyridine derivatives target cell membrane and trigger death receptors-mediated apoptosis in cancer cells.
    Deng Z; Gao P; Yu L; Ma B; You Y; Chan L; Mei C; Chen T
    Biomaterials; 2017 Jun; 129():111-126. PubMed ID: 28340357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.
    Zhao Z; Luo Z; Wu Q; Zheng W; Feng Y; Chen T
    Dalton Trans; 2014 Dec; 43(45):17017-28. PubMed ID: 25087850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mono- and Dinuclear Phosphorescent Rhenium(I) Complexes: Impact of Subcellular Localization on Anticancer Mechanisms.
    Ye RR; Tan CP; Chen MH; Hao L; Ji LN; Mao ZW
    Chemistry; 2016 Jun; 22(23):7800-9. PubMed ID: 27106876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aquation Is a Crucial Activation Step for Anticancer Action of Ruthenium(II) Polypyridyl Complexes to Trigger Cancer Cell Apoptosis.
    Li M; Lai L; Zhao Z; Chen T
    Chem Asian J; 2016 Jan; 11(2):310-20. PubMed ID: 26507802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, DNA interaction, antioxidant and anticancer activity studies of ruthenium(II) polypyridyl complexes.
    Jiang GB; Xie YY; Lin GJ; Huang HL; Liang ZH; Liu YJ
    J Photochem Photobiol B; 2013 Dec; 129():48-56. PubMed ID: 24177204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-Oxidant Activity of Amine-Pyridine-Based Iron Complexes Efficiently Kills Cancer and Cancer Stem-Like Cells.
    González-Bártulos M; Aceves-Luquero C; Qualai J; Cussó O; Martínez MA; Fernández de Mattos S; Menéndez JA; Villalonga P; Costas M; Ribas X; Massaguer A
    PLoS One; 2015; 10(9):e0137800. PubMed ID: 26368127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biological effect of the nitroimidazole derivative of a polypyridyl ruthenium complex on cancer and endothelial cells.
    Mazuryk O; Suzenet F; Kieda C; Brindell M
    Metallomics; 2015 Mar; 7(3):553-66. PubMed ID: 25711770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells.
    Du Y; Fu X; Li H; Chen B; Guo Y; Su G; Zhang H; Ning F; Lin Y; Mei W; Chen T
    ChemMedChem; 2014 Apr; 9(4):714-8. PubMed ID: 24403015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium polypyridyl complexes that induce mitochondria-mediated apoptosis in cancer cells.
    Chen T; Liu Y; Zheng WJ; Liu J; Wong YS
    Inorg Chem; 2010 Jul; 49(14):6366-8. PubMed ID: 20527894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity, apoptosis, cellular uptake, cell cycle distribution, and DNA-binding investigation of ruthenium complexes.
    Guo QF; Liu SH; Liu QH; Xu HH; Zhao JH; Wu HF; Li XY; Wang JW
    DNA Cell Biol; 2012 Jul; 31(7):1205-13. PubMed ID: 22424392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data on the characterization and anticancer action of iron(II) polypyridyl complexes.
    Chen J; Luo Z; Zhao Z; Xie L; Zheng W; Chen T
    Data Brief; 2016 Sep; 8():670-86. PubMed ID: 27453925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionalized Multiwalled Carbon Nanotubes as Carriers of Ruthenium Complexes to Antagonize Cancer Multidrug Resistance and Radioresistance.
    Wang N; Feng Y; Zeng L; Zhao Z; Chen T
    ACS Appl Mater Interfaces; 2015 Jul; 7(27):14933-45. PubMed ID: 26107995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein binding and anticancer activity studies of ruthenium(II) polypyridyl complexes toward BEL-7402 cells.
    Lai SH; Li W; Yao JH; Han BJ; Jiang GB; Zhang C; Zeng CC; Liu YJ
    J Photochem Photobiol B; 2016 May; 158():39-48. PubMed ID: 26945645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between polypyridyl and cyclometalated ruthenium(II) complexes: anticancer activities against 2D and 3D cancer models.
    Huang H; Zhang P; Chen H; Ji L; Chao H
    Chemistry; 2015 Jan; 21(2):715-25. PubMed ID: 25388328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruthenium(II) polypyridyl complexes: cellular uptake, cell image and apoptosis of HeLa cancer cells induced by double targets.
    Yu Q; Liu Y; Xu L; Zheng C; Le F; Qin X; Liu Y; Liu J
    Eur J Med Chem; 2014 Jul; 82():82-95. PubMed ID: 24878637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization and anticancer activity studies of ruthenium(II) polypyridyl complexes on A549 cells.
    Zeng CC; Jiang GB; Lai SH; Zhang C; Yin H; Tang B; Wan D; Liu YJ
    J Photochem Photobiol B; 2016 Aug; 161():295-303. PubMed ID: 27288660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruthenium(II) complexes: DNA-binding, cytotoxicity, apoptosis, cellular localization, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential and western blot analysis.
    Li W; Jiang GB; Yao JH; Wang XZ; Wang J; Han BJ; Xie YY; Lin GJ; Huang HL; Liu YJ
    J Photochem Photobiol B; 2014 Nov; 140():94-104. PubMed ID: 25108205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization and anticancer effect of the ruthenium (II) polypyridyl complexes on HepG2 cells.
    Wan D; Lai SH; Yang HH; Tang B; Zhang C; Yin H; Zeng CC; Liu YJ
    J Photochem Photobiol B; 2016 Dec; 165():246-255. PubMed ID: 27816647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contrasting activity of iodido versus chlorido ruthenium and osmium arene azo- and imino-pyridine anticancer complexes: control of cell selectivity, cross-resistance, p53 dependence, and apoptosis pathway.
    Romero-Canelón I; Salassa L; Sadler PJ
    J Med Chem; 2013 Feb; 56(3):1291-300. PubMed ID: 23368735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.